We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
LKQ Corp
LKQ
$6.25B
| $17.9K | ﹤0.01% |
593
-36,462
| -98% | -$1.1M |
|
|
HPP
1552
Hudson Pacific Properties
HPP
$777M
| $17.1K | ﹤0.01% |
1,582
+395
| +33% | +$5.87K |
|
1553
Aura Biosciences
AURA
$802M
| $16.8K | ﹤0.01% |
3,086
+684
| +28% | +$4.06K |
|
1554
SAP
SAP
$236B
| $16.8K | ﹤0.01% |
69
| – | – |
|
|
CBL
1555
CBL Properties
CBL
$1.77B
| $16.7K | ﹤0.01% |
452
+113
| +33% | +$3.69K |
|
1556
Riot Platforms
RIOT
$7.63B
| $16.3K | ﹤0.01% |
1,290
+228
| +21% | +$3.9K |
|
|
BCYC
1557
Bicycle Therapeutics
BCYC
$284M
| $15.9K | ﹤0.01% |
2,248
+461
| +26% | +$3.4K |
|
1558
Aclaris Therapeutics
ACRS
$860M
| $15.8K | ﹤0.01% |
+5,265
| New | +$13.3K |
|
1559
Larimar Therapeutics
LRMR
$454M
| $15.8K | ﹤0.01% |
4,159
+850
| +26% | +$3.31K |
|
1560
Albertsons Companies
ACI
$5.83B
| $15.7K | ﹤0.01% |
912
-1,612
| -64% | -$28.7K |
|
1561
Core Scientific
CORZ
$6.71B
| $15.6K | ﹤0.01% |
1,073
+181
| +20% | +$3.16K |
|
1562
Shift4
FOUR
$3.47B
| $15.6K | ﹤0.01% |
248
+42
| +20% | +$2.97K |
|
1563
Neurogene
NGNE
$738M
| $15.5K | ﹤0.01% |
753
+201
| +36% | +$5K |
|
|
AHRT
1564
AH Realty Trust
AHRT
$501M
| $15.5K | ﹤0.01% |
2,343
+587
| +33% | +$3.87K |
|
|
INN
1565
Summit Hotel Properties
INN
$655M
| $15.5K | ﹤0.01% |
3,181
+723
| +29% | +$3.78K |
|
1566
Anavex Life Sciences
AVXL
$316M
| $15.5K | ﹤0.01% |
4,342
+1,021
| +31% | +$6.25K |
|
1567
AC Immune
ACIU
$267M
| $15.3K | ﹤0.01% |
4,879
+997
| +26% | +$3.15K |
|
|
CAN
1568
Canaan Creative
CAN
$154M
| $15.3K | ﹤0.01% |
22,127
+9,104
| +70% | +$10.4K |
|
1569
Candel Therapeutics
CADL
$783M
| $15.1K | ﹤0.01% |
+2,668
| New | +$14.4K |
|
1570
Hyatt Hotels
H
$16.8B
| $15.1K | ﹤0.01% |
94
+11
| +13% | +$1.69K |
|
1571
StoneCo
STNE
$2.43B
| $15K | ﹤0.01% |
1,014
+171
| +20% | +$2.86K |
|
1572
Allogene Therapeutics
ALLO
$714M
| $15K | ﹤0.01% |
10,920
+2,342
| +27% | +$3.09K |
|
1573
Lifecore Biomedical
LFCR
$181M
| $14.9K | ﹤0.01% |
+1,821
| New | +$13.5K |
|
1574
Foghorn Therapeutics
FHTX
$394M
| $14.8K | ﹤0.01% |
2,748
+563
| +26% | +$2.55K |
|
|
BDN
1575
Brandywine Realty Trust
BDN
$541M
| $14.8K | ﹤0.01% |
5,077
+1,288
| +34% | +$4.38K |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.